Live Breaking News & Updates on Both Dosage Strengths Versus Placebo

Insmed Announces Positive Topline Results from Landmark ASPEN Study of Brensocatib in Patients with Bronchiectasis
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United Kingdom , New Jersey , United States , Bryan Dunn , Mandy Fahey , James Chalmers , Eleanor Barisser , Martina Flammer , Esteve Pharmaceuticals , Prnewswire Insmed Incorporated Nasdaq , Company Annual Report On Form , Corporate Communications , School Of Medicine , Insmed Incorporated , Exchange Commission , Drug Administration , Thermo Fisher Scientific Inc , European Medicines Agency , University Of Dundee , Achieves Primary Endpoint , Both Dosage Strengths , Statistically Significant , Clinically Meaningful Reduction , Pulmonary Exacerbations Versus Placebo , Multiple Secondary Endpoints , Both Dosage Strengths Versus Placebo ,